Research News
featuring Peter Calabresi, MD
This video webcast series will focus on:
Part One
Length of program: 10 minutes
Downloads: Transcript (.pdf) | Podcast (.mp3)
Topics:
- Oral treatments
- Genetics research
- Stopping MS progression
Part Two
Length of program: 10 minutes
Downloads: Transcript (.pdf) | Podcast (.mp3)
Topics:
- Advances in imaging
- Characteristics of MS lesions
- The latest on Tysabri
UPDATE: In this webcast, 4-aminopyridine clinical trial results were discussed. On January 22, 2010, 4-aminopyridine was approved by the FDA under the brand name Ampyra after showing to improve walking. If you would like more information on this recent development, please watch the webcast Ampyra: A New Medication to Improve Walking.